Tasia Blazevich

Tasia has over 20 years of experience working with public and private companies in the life science, consumer products and technology industries, and has spent the last 10 years specializing in emerging growth biotech and early-stage pharmaceutical companies. She currently serves as the US Life Sciences IPO Co-Leader with expertise in complex technical accounting, transaction support services (IPO, Reverse-Merger, SPAC), SEC reporting, financial statement reporting, and Sarbanes-Oxley implementation and compliance and ESG. She is the San Diego Market Leader for the Accounting & Reporting Advisory Services (ARA) practice, with a proven track record of new business development and brand/market awareness. Tasia has strong communications skills, with a focus on fostering a collaborative team environment. She is an emotionally intelligent leader who is passionate about mentoring, coaching and people development. Tasia is detail oriented and goal focused professional who is driven to produce results. Prior to serving in this role, Tasia specialized in auditing emerging growth biotech and early stage pharmaceutical companies in the San Diego market, and prior to that, worked in the private sector in various SEC Reporting and Technical Accounting roles.